UT Tyler School of Medicine Professor Advancing Antibiotic Treatment for Nontuberculous Mycobacteria Lung Disease
July 11, 2023
July 11, 2023
TYLER, Texas, July 11 (TNSjou) -- The University of Texas Tyler Campus issued the following news release:
Dr. Shashikant Srivastava, a University of Texas at Tyler School of Medicine associate professor, advanced an oral antibiotic for the treatment of Mycobacterium abscessus lung disease.
The bacteria, Mycobacterium abscessus, belongs to group of nontuberculous mycobacteria and is naturally resistant to many antibiotics. Current treatment including injectable drugs is . . .
Dr. Shashikant Srivastava, a University of Texas at Tyler School of Medicine associate professor, advanced an oral antibiotic for the treatment of Mycobacterium abscessus lung disease.
The bacteria, Mycobacterium abscessus, belongs to group of nontuberculous mycobacteria and is naturally resistant to many antibiotics. Current treatment including injectable drugs is . . .